Polymer-free drug-coated coronary stents are cost-effective in patients at high bleeding risk: economic evaluation of the LEADERS FREE trial

Antoine Filipovic-Pierucci1*, MD, MPH; Isabelle Durand-Zaleski1,2,3, MD, PhD; Thibault Butel1, MD, MPH; Samantha Greene4, BA; Thomas Hovasse5, MD; Andres Iñiguez6, MD, PhD, FESC; Marco Stefano Nazzaro7, MD, PhD; Keith G. Oldroyd8, MBChB, MD; Suneel Talwar9, MBBS, MRCP, MD; Gert Richardt10, MD; Ute Windhovel11, PhD; Philip Urban12, MD; Marie-Claude Morice5, MD; for the LEADERS FREE investigators